Keto-diet champions will like the new food pyramid’s emphasis on proteins, including those high in saturated fats. Not everyone shares their predisposition. 

Lawyers representing Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, cite Attorney General Pam Bondi's tenure with Ballard Partners, a lobbying firm whose clients include UnitedHealth, as evidence of her conflict of interest. In response, the prosecution called the claim “misleading.”

During a recent segment on Fox Business, Food and Drug Administration Commissioner Martin Makary, MD, clarified new guidance on AI, meant to provide companies with the flexibility to gather and provide data without the agency's approval. However, medical devices that provide "clinical-grade" data will still need to be cleared.

The endorsement follows recent program updates, implemented following an expansion to the Scope of Practice and Clinical Standards for the Diagnostic Medical Sonographer.

A veteran cardiologist is back on the job after reportedly being fired for his participation in a controversial CDC panel. His wife shared the update, saying they were "truly humbled" by everyone who came to his defense.

An impending policy change from UHC could cause providers to jump through additional hoops to receive payment for some imaging-related services. 

Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy. 

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.